Trevor Ajan Reginald
Oprichter bij Oncogeni Ltd.
Profiel
Trevor Ajan Reginald is the founder of Oncogeni Ltd.
which is founded in 2019, where he holds the title of Director.
He is currently working as a Director at Desktop Genetics Ltd.
where he started in 2018 and still holds the position.
Actieve functies van Trevor Ajan Reginald
| Bedrijven | Functie | Begin |
|---|---|---|
Desktop Genetics Ltd.
 Desktop Genetics Ltd. Packaged SoftwareTechnology Services Desktop Genetics Ltd. develops software tools to enable literal desktop genetics. It offers technologies at the intersection of biotechnology, software and laboratory automation. The firm specializes in synthetic biology, genome engineering, genome editing, functional genomics, bioinformatics, and screening. The company was founded by Victor Dillard, Riley Doyle and Edward Perello in 2012 and is headquartered in London, the United Kingdom. | Directeur/Bestuurslid | 04-06-2018 |
Oncogeni Ltd.
 Oncogeni Ltd. BiotechnologyHealth Technology Part of Roquefort Therapeutics Plc, Oncogeni Ltd. operates as a British biotechnology company. The company is based in Stratford-upon-Avon, UK. The company was founded in 2019 by Nobel Laureate, Martin John Evans, Trevor Ajan Reginald. Oncogeni was acquired by Roquefort Therapeutics Plc on September 16, 2022 for $4.61 million. | Oprichter | 01-05-2019 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Desktop Genetics Ltd.
Desktop Genetics Ltd. Packaged SoftwareTechnology Services Desktop Genetics Ltd. develops software tools to enable literal desktop genetics. It offers technologies at the intersection of biotechnology, software and laboratory automation. The firm specializes in synthetic biology, genome engineering, genome editing, functional genomics, bioinformatics, and screening. The company was founded by Victor Dillard, Riley Doyle and Edward Perello in 2012 and is headquartered in London, the United Kingdom. | Technology Services |
Oncogeni Ltd.
Oncogeni Ltd. BiotechnologyHealth Technology Part of Roquefort Therapeutics Plc, Oncogeni Ltd. operates as a British biotechnology company. The company is based in Stratford-upon-Avon, UK. The company was founded in 2019 by Nobel Laureate, Martin John Evans, Trevor Ajan Reginald. Oncogeni was acquired by Roquefort Therapeutics Plc on September 16, 2022 for $4.61 million. | Health Technology |
